AGTR1 and atherosclerosis: In particular, in full accordance with what is described in the atherosclerosis section, AGTR1 is a target for miR-155-5p, miR-34a-5p, and 11 drugs acting as angiotensin II receptor type 1 (AT1) antagonists, with its most widely studied polymorphism, rs5186, to be also associated in the connection map (Figure 4).